255 related articles for article (PubMed ID: 34335580)
1. Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19.
Acevedo N; Escamilla-Gil JM; Espinoza H; Regino R; Ramírez J; Florez de Arco L; Dennis R; Torres-Duque CA; Caraballo L
Front Immunol; 2021; 12():678661. PubMed ID: 34335580
[TBL] [Abstract][Full Text] [Related]
2. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
Callahan V; Hawks S; Crawford MA; Lehman CW; Morrison HA; Ivester HM; Akhrymuk I; Boghdeh N; Flor R; Finkielstein CV; Allen IC; Weger-Lucarelli J; Duggal N; Hughes MA; Kehn-Hall K
Viruses; 2021 Jun; 13(6):. PubMed ID: 34205098
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.
Ruhl L; Pink I; Kühne JF; Beushausen K; Keil J; Christoph S; Sauer A; Boblitz L; Schmidt J; David S; Jäck HM; Roth E; Cornberg M; Schulz TF; Welte T; Höper MM; Falk CS
Signal Transduct Target Ther; 2021 Dec; 6(1):418. PubMed ID: 34893580
[TBL] [Abstract][Full Text] [Related]
4. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.
Song J; Zeng M; Wang H; Qin C; Hou HY; Sun ZY; Xu SP; Wang GP; Guo CL; Deng YK; Wang ZC; Ma J; Pan L; Liao B; Du ZH; Feng QM; Liu Y; Xie JG; Liu Z
Allergy; 2021 Feb; 76(2):483-496. PubMed ID: 32716553
[TBL] [Abstract][Full Text] [Related]
5. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
6. Systemic Inflammation in Preclinical Ulcerative Colitis.
Bergemalm D; Andersson E; Hultdin J; Eriksson C; Rush ST; Kalla R; Adams AT; Keita ÅV; D'Amato M; Gomollon F; Jahnsen J; ; Ricanek P; Satsangi J; Repsilber D; Karling P; Halfvarson J
Gastroenterology; 2021 Nov; 161(5):1526-1539.e9. PubMed ID: 34298022
[TBL] [Abstract][Full Text] [Related]
7. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
8. Plasma Chemokine signature correlates with lung goblet cell hyperplasia in smokers with and without chronic obstructive pulmonary disease.
Kim V; Cornwell WD; Oros M; Durra H; Criner GJ; Rogers TJ
BMC Pulm Med; 2015 Sep; 15():111. PubMed ID: 26424214
[TBL] [Abstract][Full Text] [Related]
9. A Comparative Study of the Plasma Chemokine Profile in COVID-19 Patients Infected with Different SARS-CoV-2 Variants.
Korobova ZR; Arsentieva NA; Liubimova NE; Dedkov VG; Gladkikh AS; Sharova AA; Chernykh EI; Kashchenko VA; Ratnikov VA; Gorelov VP; Stanevich OV; Kulikov AN; Pevtsov DE; Totolian AA
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012323
[TBL] [Abstract][Full Text] [Related]
10. The relationship between inflammatory markers and spirometric parameters in ACOS, Asthma, and COPD.
Uzan GC; Borekci S; Doventas YE; Koldas M; Gemicioglu B
J Asthma; 2020 Dec; 57(12):1273-1279. PubMed ID: 31403365
[No Abstract] [Full Text] [Related]
11. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
[TBL] [Abstract][Full Text] [Related]
12. Identification of CXCL9 chemokine as a potential biomarker for assessing clinical severity in COVID-19 patients.
Ibadullaeva N; Khikmatullaeva A; Mirzaev U; Kan N; Bobkova M; Musabaev E
J Infect Dev Ctries; 2024 May; 18(5):672-678. PubMed ID: 38865391
[TBL] [Abstract][Full Text] [Related]
13. The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression.
Yin X; Wang Z; Wu T; Ma M; Zhang Z; Chu Z; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
J Transl Med; 2019 Dec; 17(1):417. PubMed ID: 31836011
[TBL] [Abstract][Full Text] [Related]
14. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
15. [THE ROLE OF CYTOKINES AND CHEMOKINES IN LABORATORY DIAGNOSTIC OF CHRONIC VIRAL HEPATITIS C].
Semenov AV; Arsentieva NA; Lubimova NE; Tulienev SV; Basina VV; Esaulenko EV; Totolyan AA
Klin Lab Diagn; 2015 Aug; 60(8):45-51. PubMed ID: 26596048
[TBL] [Abstract][Full Text] [Related]
16. Concentration of CCL11, CXCL8 and TNF-alpha in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbation.
Daldegan MB; Teixeira MM; Talvani A
Braz J Med Biol Res; 2005 Sep; 38(9):1359-65. PubMed ID: 16138219
[TBL] [Abstract][Full Text] [Related]
17. An immune-based biomarker signature is associated with mortality in COVID-19 patients.
Abers MS; Delmonte OM; Ricotta EE; Fintzi J; Fink DL; de Jesus AAA; Zarember KA; Alehashemi S; Oikonomou V; Desai JV; Canna SW; Shakoory B; Dobbs K; Imberti L; Sottini A; Quiros-Roldan E; Castelli F; Rossi C; Brugnoni D; Biondi A; Bettini LR; D'Angio' M; Bonfanti P; Castagnoli R; Montagna D; Licari A; Marseglia GL; Gliniewicz EF; Shaw E; Kahle DE; Rastegar AT; Stack M; Myint-Hpu K; Levinson SL; DiNubile MJ; Chertow DW; Burbelo PD; Cohen JI; Calvo KR; Tsang JS; ; Su HC; Gallin JI; Kuhns DB; Goldbach-Mansky R; Lionakis MS; Notarangelo LD
JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33232303
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
19. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
mBio; 2021 May; 12(3):. PubMed ID: 33947753
[TBL] [Abstract][Full Text] [Related]
20. Change of Serum Inflammatory Cytokines Levels in Patients With Chronic Obstructive Pulmonary Disease, Pneumonia and Lung Cancer.
Chen J; Li X; Huang C; Lin Y; Dai Q
Technol Cancer Res Treat; 2020; 19():1533033820951807. PubMed ID: 33111646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
